Interview with Jaime Cervantes Covarrubias, General Manager, Grupo Vitalmex…
Can you give us a historical overview of the company and tell us about the vision behind its creation? Vitalmex is a very humanistic company that puts the patient at…
Address: Bvd. Adolfo Ruiz Cortines 4284 Jardines del Pedregal, Alvaro Obregon, 04500, México D.F.,Mexico
Tel: 55 5424 6303
Web: http://www.vitalmex.com.mx/
Vitalmex was created 20 years ago and tried to develop a new business model. We were pioneers as we were the first integrator in the country, creating the comodato system (when the government buys equipment, they have to buy all the accessories from the same provider) and the first integrated services model. It means that innovation, medicines, information, technology, financing, are articulated around the patient needs.
Vitalmex’s product portfolio features: innovation services, tailor-made projects and integral medical services.
Can you give us a historical overview of the company and tell us about the vision behind its creation? Vitalmex is a very humanistic company that puts the patient at…
Chiesi Mexico’s Marco Ruggiero discusses his initial impressions of the Mexican pharma market, his strategic priorities for the affiliate, and the increasing importance of the company’s respiratory portfolio in Mexico.…
Novartis Mexico Country President Fernando Cruz outlines the new normal for Mexican healthcare post-regulatory reform, how the company’s global reshuffle has impacted Mexican operations, and the challenges inherent in bringing…
David López García, Mexico country manager of global rare genetic therapy player Biomarin, outlines the challenging situation around patient access to orphan drugs in Mexico and the importance of building…
Dr David Kershenobich Stalnikowitz, director-general of the Salvador Zubirán National Institute of Medical Sciences and Nutrition (INCMNSZ) shares the many new initiatives the Institute has introduced in the past couple…
In the historic year of their 70th anniversary, Cristóbal Thompson, executive director of the Asociación Mexicana de Industrias de Investigación Farmacéutica (AMIIF), the association for research-based pharmaceutical companies in Mexico,…
Rafael Gual Cosío, director general of the Cámara Nacional de la Industria Farmacéutica (CANIFARMA), the umbrella industry association for the healthcare sector in Mexico, shares his perspectives on the complex…
The election of populist President Andres Manuel Lopez Obrador (AMLO) on 1 July 2018 heralded a new era of hope and optimism for Mexicans. In the first 13 months of…
Juan de Villafranca, executive director of the Asociacion Mexicana de Laboratorios Farmaceuticos (AMELAF), shares the exciting new initiatives he has launched in the past two years of his term; the…
Below is a selection of top recent news from Mexican pharma and healthcare, including the healthcare reforms president Andres Manuel Lopez Obrador is prioritising, latest news on the INSABI program,…
Between 2015 and 2017 PharmaBoardroom met with pharma country managers in Mexico who spoke about the challenges and opportunities present in the Mexican market. Since then, these five stakeholders have…
The United States Trade Representative Office has been engaging with a number of countries, including Mexico, to address concerns related to IP protection and enforcement and market access barriers for…
What traits, competencies and drivers do you need to be a successful pharma country manager in today’s dynamic Mexican pharma market? Jose Guerrero and Male Mejido from the Mexico office…
See our Cookie Privacy Policy Here